Assembly Biosciences Inc (ASMB)
16.30
-0.59
(-3.49%)
USD |
NASDAQ |
Nov 04, 16:00
16.30
0.00 (0.00%)
After-Hours: 20:00
Assembly Biosciences Max Drawdown (5Y): 98.33% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
October 31, 2024 | 98.33% |
September 30, 2024 | 98.33% |
August 31, 2024 | 98.33% |
July 31, 2024 | 98.33% |
June 30, 2024 | 98.33% |
May 31, 2024 | 98.33% |
April 30, 2024 | 98.33% |
March 31, 2024 | 98.33% |
February 29, 2024 | 98.33% |
January 31, 2024 | 98.33% |
December 31, 2023 | 98.33% |
November 30, 2023 | 98.33% |
October 31, 2023 | 98.33% |
September 30, 2023 | 98.33% |
August 31, 2023 | 98.33% |
July 31, 2023 | 98.33% |
June 30, 2023 | 98.33% |
May 31, 2023 | 98.33% |
April 30, 2023 | 98.33% |
March 31, 2023 | 98.33% |
February 28, 2023 | 98.30% |
January 31, 2023 | 98.30% |
December 31, 2022 | 98.30% |
November 30, 2022 | 97.97% |
October 31, 2022 | 97.90% |
Date | Value |
---|---|
September 30, 2022 | 97.90% |
August 31, 2022 | 97.90% |
July 31, 2022 | 97.90% |
June 30, 2022 | 97.90% |
May 31, 2022 | 97.90% |
April 30, 2022 | 97.72% |
March 31, 2022 | 97.72% |
February 28, 2022 | 97.72% |
January 31, 2022 | 97.35% |
December 31, 2021 | 96.68% |
November 30, 2021 | 96.49% |
October 31, 2021 | 95.20% |
September 30, 2021 | 95.11% |
August 31, 2021 | 94.72% |
July 31, 2021 | 94.72% |
June 30, 2021 | 94.08% |
May 31, 2021 | 94.08% |
April 30, 2021 | 93.63% |
March 31, 2021 | 93.25% |
February 28, 2021 | 92.99% |
January 31, 2021 | 94.02% |
December 31, 2020 | 94.37% |
November 30, 2020 | 95.52% |
October 31, 2020 | 95.52% |
September 30, 2020 | 95.52% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
92.99%
Minimum
Feb 2021
98.33%
Maximum
Mar 2023
96.81%
Average
97.81%
Median
Max Drawdown (5Y) Benchmarks
ADMA Biologics Inc | 84.77% |
Sensus Healthcare Inc | 87.51% |
Protagonist Therapeutics Inc | 85.79% |
Precision BioSciences Inc | 98.57% |
Entrada Therapeutics Inc | -- |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -48.83 |
Beta (5Y) | 0.5827 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 60.95% |
Historical Sharpe Ratio (5Y) | -0.6777 |
Historical Sortino (5Y) | -0.9803 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 27.15% |